Arlington Capital Partners
About
Arlington Capital Partners is a Washington DC private equity firm specialising in regulated industries, with over $14bn in committed capital across seven funds and roughly 200 transactions since 1999. Fund VI closed at $3.8bn in 2024 and Fund VII at $6bn is now deploying. The firm runs four verticals: aerospace and defence, government services and technology, healthcare and business services. Portfolio includes Verus Aerospace, Stellant Systems (sold to TransDigm for $960m), GRVTY and AVS Bio.
Industries
Stage focus
Series B+
Geography
USGlobal
Notable investments
- GRVTY
- Systems Planning & Analysis
- Stellant Systems
- AVS Bio
Raising from Arlington Capital Partners?
I've worked with founders across the industrial stack. If Arlington Capital Partners is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan